焦磷酸钙沉积与肾结石风险增加相关:一项队列研究
该回顾性队列研究利用美国退伍军人事务部国家企业数据仓库,纳入2010年1月1日至2014年12月31日期间至少有一次住院或门诊ICD9编码为焦磷酸钙沉积病(CPPD)的患者,按年龄、性别和日期与最多4名对照匹配。共识别18,761例CPPD患者和75,043名对照(总样本93,804人),CPPD队列肾结石患病率为8.6%,显著高于对照组的5.1%(P<.0001);校正分析显示CPPD患者肾结石的比值比为1.659(95%CI 1.560, 1.764),去除甲状旁腺功能亢进患者后仍显著。作者认为CPPD是肾结石形成的独立危险因素。
要点
- CPPD患者肾结石患病率为8.6%,显著高于对照组的5.1%(P<.0001)。
- 校正分析显示CPPD患者肾结石的比值比为1.659(95%CI 1.560, 1.764)。
- 去除甲状旁腺功能亢进患者后,CPPD与肾结石的关联仍显著。
核心结论
- 这些数据提示CPPD是肾结石形成的独立危险因素,并进一步支持CPPD是一种具有关节外表现的全身性矿化疾病的假说。
研究设计与样本
- 回顾性队列研究,使用美国退伍军人事务部国家企业数据仓库识别2010年1月1日至2014年12月31日期间至少有一次住院或门诊ICD9编码为CPPD的患者,按年龄、性别和日期与最多4名对照匹配。
- 共识别18,761例CPPD患者,匹配75,043名对照,总样本量93,804人;队列平均年龄68.5岁,男性占94.3%。
- 两队列均记录肾结石的独立危险因素,包括甲状旁腺功能亢进、肾小管酸中毒、炎症性肠病、短肠综合征和肥胖(BMI>30)。
主要发现
- CPPD队列肾结石患病率为8.6%,显著高于对照组的5.1%(P<.0001)。
- 校正分析显示CPPD患者肾结石的比值比为1.659(95%CI 1.560, 1.764)。
- 去除甲状旁腺功能亢进患者后,CPPD与肾结石的关联仍显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVE: Calcium pyrophosphate deposition disease (CPPD) is a type of arthritis affecting aging adults that presents with chronic and acute inflammatory and non-inflammatory joint disease. While the etiology of CPPD is not fully understood, recent work suggests that it may be associated with other mineralization disorders. In this retrospective cohort study, we investigated the hypothesis that the prevalence of nephrolithiasis is increased in patients with CPPD. METHODS: We used the National VA Corporate Data Warehouse to identify CPPD patients with at least one inpatient or outpatient ICD9 code for CPPD between January 1, 2010 and December 31, 2014. This disease cohort was age-, sex-, and date-matched to up to four controls. The presence of independent risk factors for nephrolithiasis was noted for both cohorts, including hyperparathyroidism, renal tubular acidosis, inflammatory bowel disease, short gut syndrome, and obesity (BMI > 30). RESULTS: A total of 18,761 CPPD patients were identified who were matched by age and sex to 75,043 controls, for a total sample size of 93,804 individuals. The average age of the cohorts was 68.5 years, with a predominant male demographic (94.3 %). The prevalence of nephrolithiasis was significantly higher in the CPPD cohort (8.6 %) compared to controls (5.1 %, P < .0001). Adjusted analyses revealed an odds ratio of 1.659 (95 % CI 1.560, 1.764) for nephrolithiasis in CPPD patients which remained significant after removal of patients with hyperparathyroidism. CONCLUSIONS: These data suggest that CPPD is an independent risk factor for kidney stone formation and provide further support for the hypothesis that CPPD is a systemic disorder of mineralization with extra-articular implications.
引用
- Mirza M, Fernandes A, Sherman K, et al. Calcium pyrophosphate deposition is associated with an increased risk for nephrolithiasis: A cohort study. Semin Arthritis Rheum. 2025. PMID: 39893939. doi:10.1016/j.semarthrit.2025.152641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。